Thu, December 2, 2010
Wed, December 1, 2010
Tue, November 30, 2010
[ Tue, Nov 30th 2010 ] - Market Wire
2005 Certification
Mon, November 29, 2010
Thu, November 25, 2010
Wed, November 24, 2010
Tue, November 23, 2010
Mon, November 22, 2010
Sat, November 20, 2010
Fri, November 19, 2010
Thu, November 18, 2010
Wed, November 17, 2010
Tue, November 16, 2010
Mon, November 15, 2010
Sun, November 14, 2010
Fri, November 12, 2010
Thu, November 11, 2010
Wed, November 10, 2010
Tue, November 9, 2010
Mon, November 8, 2010

St. Jude Medical To Present at the 22nd Annual Piper Jaffray Health Care Conference


//health-fitness.news-articles.net/content/2010/ .. annual-piper-jaffray-health-care-conference.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


ST. PAUL, Minn.--([ BUSINESS WIRE ])--St. Jude Medical, Inc. (NYSE:STJ) will present at the 22nd Annual Piper Jaffray Health Care Conference on Tuesday, November 30, in New York City. John C. Heinmiller, executive vice president and chief financial officer, will address the conference at 8:00 a.m. ET. The presentation will also be webcast live at [ www.sjm.com ].

About St. Jude Medical

St. Jude Medical, Inc. develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. St. Jude Medical is headquartered in St. Paul, Minn. and has four major focus areas that include cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. For more information, please visit [ www.sjm.com ].

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the Company are based upon managementa�s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Companya�s control and the risk factors and other cautionary statements described in the Companya�s filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Companya�s Quarterly Report on Form 10-Q for the fiscal quarter ended October 2, 2010.The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.


Publication Contributing Sources